Lv1
20 积分 2024-12-24 加入
Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma
26天前
已完结
The present and the future of immunotherapy in hepatocellular carcinoma and biliary tract cancers
26天前
已完结
Risk prediction criteria for the primary hepatic perivascular epithelioid cell tumour family, including angiomyolipoma: analysis of 132 cases with a literature review
2个月前
已完结
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
2个月前
已完结
Identification of key genes involved in JAK/STAT pathway in colorectal cancer
3个月前
已完结
The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic Opportunities
5个月前
已完结
The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression
6个月前
已完结
The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment
6个月前
已完结
Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity
6个月前
已完结
Immunotherapies for hepatocellular carcinoma
6个月前
已关闭
皖公网安备34019202002308
